Quantum Exponential - Result of AGM
RNS Number : 2174H
Quantum Exponential Group PLC
22 November 2022

22 November 2022

Quantum Exponential Group plc

(the 'Company' or 'Quantum Exponential' or 'QBIT')

Result of AGM


Quantum Exponential Group plc (AQUIS: QBIT), a company focused on investing in quantum technology, is pleased to announce that all resolutions have been duly passed at the Company's Annual General Meeting ('AGM') held earlier today.




For more information, visit the Company's website: https://quantumexp.co.uk/ or contact:

Quantum Exponential

Steven Metcalfe, Chief Executive Officer



Novum Securities (AQSE Corporate Adviser)

David Coffman, George Duxberry


Tel: +44 (0)20 7399 9400


Oberon Capital (Broker) 

Mike Seabrook, Chris Crawford


Tel: +44 (0)20 3179 5344

St Brides Partners Limited (Financial PR)

Catherine Leftley, Ana Ribeiro, Isabelle Morris




About Quantum Exponential Group plc

Quantum Exponential is a first of its kind, AQSE Growth Market enterprise company, focused on opportunities in quantum technology and the wider quantum computing sector, with an advisory board made up of industry advisors, entrepreneurs, and technology investment professionals with broad access to quantum opportunities and markets. Quantum Exponential's investment strategy is to assemble a portfolio of minority investments in early-stage global quantum technology companies, primarily in NATO allied countries, offering institutional and private investors access to revolutionising technologies and industries in the realms of artificial intelligence, manufacturing and healthcare.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.